CClinicalTrials.gg
CompletedNCT04483362Updated Jun 3, 2022

CanMove: A Physical Activity Program for Children With Cancer

An interventional study of Complex physical activity intervention in Pediatric Cancer, sponsored by Murdoch Childrens Research Institute. Completed at 1 site in Australia. Open to participants aged 5 Years to 17 Years. Per ClinicalTrials.gov, last updated 2022-06-03.

Sponsored by Murdoch Childrens Research Institute · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
21
Allocation
Not applicable
Ages
5 Years to 17 Years
Sex
All
01

Study summary

This study will evaluate a physical activity intervention for children during acute cancer treatment. The intervention aims to encourage children to participate in increased levels of physical activity and reduce the amount of time they spend engaged in sedentary activities. This study also aims to evaluate different ways of assessing physical function in order to determine the best outcome measure to use for children during acute cancer treatment.

Read the detailed description

All participants will receive the intervention which involves weekly sessions with a physiotherapist and the provision of an activity tracker. The sessions will aim to help motivate participants to be more physically active and identify barriers to physical activity in their environment. The activity tracker will be used to set a steps per day goal for the participant to achieve.

The intervention will be assessed for feasibility using aspects of the Bowen Framework. Under this framework the intervention will be evaluated according to different domains:

  • Acceptability: To what extent is a new idea, program, process or measure judged as suitable or satisfying
  • Demand: To what extent is a new idea, program, process, or measure likely to be used
  • Implementation: To what extent can a new program is successfully delivered to intended participants
  • Practicality: To what extent can the program can be carried out with intended participants using existing means, resources, and circumstances
  • Limited efficiency: Does the a new program show promise of being successful with the intended population

In order to find out the best way to assess physical function, participants will complete 5 different assessments. The results from these assessments will help to determine the best measure to use in this population.

02

Conditions studied

  • Pediatric Cancer

Keywords

  • physical activity
03

In context

Lead sponsor

Murdoch Childrens Research Institute is the lead sponsor of 96 studies on the registry; 34 are open to participants now.

Of its 5 completed or terminated interventional studies of FDA-regulated products, 3 (60%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
5 Years to 17 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Is between the ages of 5-17 years at the time of consent
  • Diagnosed (or relapsed) with cancer >4 weeks and \<6 months at time of consent
  • Currently receiving cancer treatment at the Royal Children's Hospital
  • Has been an in-patient for >7 consecutive days at the time of consent
  • Provide a signed and dated informed consent form and/or has a legally acceptable representative capable of understanding the informed consent document and providing consent on the participant's behalf

Exclusion criteria

Exclusion Criteria:

  • Deemed by the treating medical team as unsafe to participate
  • Child/adolescent unable to mobilise independent of clinical staff assistance, as classified by the research team at the time of consent (use of a gait aid or assistance from a primary carer/support person is accepted). For example, if a child/adolescent requires assistance from nursing staff or physiotherapist in order to walk, they will be excluded.
  • Child/adolescent unable to follow simple instructions
  • Suitable support person (18 years and over) not available to participate in continuous monitoring of daily steps in tandem with the child/adolescent
  • No suitable access to a device to sync with a Fitbit
  • Inability or unwillingness of participant or legally acceptable representative to give written informed consent.
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
21 participants (actual)

Study arms

  • Experimental
    Physical Activity

    Behavioural change techniques to promote physical activity

    Behavioral: Complex physical activity intervention

Interventions

  • BehavioralComplex physical activity intervention

    Structured weekly sessions with a Physiotherapist over an 8 week period, including: * Evaluation of current levels of physical activity and physical function - including discussion of results * Education regarding the importance of physical activity * Supervised physical activity session with a physiotherapist * Structured weekly sessions applying behavioural change techniques which aim to increase participation in physical activity. Sessions include: provision of activity monitor (Fitbit Inspire), goal setting, monitoring, collaborative problem solving and action plan implementation. Intervention includes additional time allowance of 1 hour per week to assist in implementing action plan items

06

What researchers measure

Primary outcomes

  1. Demand for the intervention

    Recruitment rate (comparing the number of people recruited to the number of potentially eligible participants), and documenting the reasons for non-participation.

    Time frame: Through completion of recruitment, estimated as 9 months

  2. Acceptability of the intervention according to participants

    Participant and participant guardian perspective on intervention satisfaction and potential areas of improvement via semi-structured interviews

    Time frame: After completion of the intervention (on average 8 weeks)

  3. Acceptability of the intervention according to staff

    Staff perspective on intervention satisfaction and potential areas of improvement via focus groups with staff members

    Time frame: Through study completion, estimated as 1 year

  4. Implementation of the intervention: adherence to wearing Fitbit

    Adherence to wearing the Fitbit for monitoring, percentage of complete Fitbit data days out of total intervention days

    Time frame: Post intervention (on average 8 weeks)

  5. Implementation of the intervention: attendance to intervention sessions

    Adherence to attending intervention sessions, percentage of intervention sessions that were attended

    Time frame: Post intervention (on average 8 weeks)

  6. Implementation of the intervention: ability for participants to attain their steps per day goal

    Goal attainment, percentage of days out of total intervention days that participant was able to achieve their steps per day target

    Time frame: Post intervention (on average 8 weeks)

  7. Practicality of the intervention: adverse events

    Measured by number of adverse events reported related to trial procedures. At each trial visit, participants will be asked "How have you felt since your last visit?" in order to elicit any changes in their well-being. They will also be asked if they have had any falls, new injuries, felt distress as a result of the intervention or experienced a change in medical or mobility status. Adverse events relevant to participant safety will also be documented from correspondence from their primary care physician or from the medical record. Adverse events recorded as serious or non-serious, related or not related to the intervention.

    Time frame: Post the participant's final trial visit (on average 12 weeks)

  8. Limited efficiency testing assessing changes in physical activity between pre and post intervention: Actigraph steps per day

    Mean change from pre to post intervention in average steps taken per day measured via the Actigraph

    Time frame: Post intervention (on average 8 weeks)

  9. Limited efficiency testing assessing changes in physical activity between pre and post intervention: Fitbit steps per day

    Mean change from pre to post intervention in average steps taken per day measured via the Fitbit

    Time frame: Post intervention (on average 8 weeks)

  10. Limited efficiency testing assessing changes in physical activity between pre and post intervention: Actigraph distance travelled per day

    Mean change from pre to post intervention in average distance travelled per day measured via the Actigraph

    Time frame: Post intervention (on average 8 weeks)

  11. Limited efficiency testing assessing changes in physical activity between pre and post intervention: Fitbit distance travelled per day

    Mean change from pre to post intervention in average distance travelled per day measured via the Fitbit

    Time frame: Post intervention (on average 8 weeks)

  12. Limited efficiency testing assessing changes in physical activity between pre and post intervention: Actigraph physical activity intensity

    Mean change from pre to post intervention in time spent in different physical activity intensities (sedentary, light, moderate-vigorous and vigorous) measured by the Actigraph

    Time frame: Post intervention (on average 8 weeks)

  13. Limited efficiency testing assessing changes in physical activity between pre and post intervention: Fitbit physical activity intensity

    Mean change from pre to post intervention in time spent in different physical activity intensities (sedentary, light, moderate-vigorous and vigorous) measured by the Fitbit

    Time frame: Post intervention (on average 8 weeks)

  14. Limited efficiency testing assessing changes in physical activity between pre and post intervention: sedentary bouts

    Mean change from pre to post intervention in number of sedentary bouts per day measured via the Actigraph

    Time frame: Post intervention (on average 8 weeks)

  15. Limited efficiency testing assessing changes in physical activity between pre and post intervention: body position

    Mean change from pre to post intervention in time spent in each body position per day measured via the Actigraph

    Time frame: Post intervention (on average 8 weeks)

  16. Limited efficiency testing assessing changes in physical activity between pre and post intervention: active hours

    Mean change from pre to post intervention in number of active hours per day measured via the Fitbit

    Time frame: Post intervention (on average 8 weeks)

  17. Limited efficiency testing assessing changes in physical activity between pre and post intervention: active minutes

    Mean change from pre to post intervention in number of active minutes per day measured via the Fitbit

    Time frame: Post intervention (on average 8 weeks)

Secondary outcomes

  1. Limited efficiency testing assessing changes in physical function from pre to post intervention: Movement ABC

    Mean score and percentile ranking measured via on the Movement ABC (a performance measure of physical function)

    Time frame: Post intervention (on average 8 weeks)

  2. Limited efficiency testing assessing changes in physical function from pre to post intervention: 6 Minute Walk Test

    Mean distance travelled measured via on the 6 Minute Walk test (a performance measure of physical fitness)

    Time frame: Post intervention (on average 8 weeks)

  3. Limited efficiency testing assessing changes in physical function from pre to post intervention: Timed Up and Go

    Mean time measured via the Timed Up and Go (a performance measure of physical function)

    Time frame: Post intervention (on average 8 weeks)

  4. Limited efficiency testing assessing changes in physical function from pre to post intervention: Timed Up and Down Stairs

    Mean time measured via the Timed Up and Down Stairs (a performance measure of physical function)

    Time frame: Post intervention (on average 8 weeks)

  5. Limited efficiency testing assessing changes in physical function from pre to post intervention: Time to Rise from the Floor

    Mean time and rating for quality of movement measured via the 30 second Chair Stand Test Assessment (a performance measure of physical function)

    Time frame: Post intervention (on average 8 weeks)

  6. Limited efficiency testing assessing changes in physical function from pre to post intervention: Time to Rise from the Floor

    Mean time and rating for quality of movement measured via the Time to Rise from the Floor Assessment (a performance measure of physical function)

    Time frame: Post intervention (on average 8 weeks)

  7. Limited efficiency testing assessing changes in Health-related Quality of Life from pre to post intervention: self-reported Pediatric Quality of Life Inventory-core generic module

    Mean score recorded on the self-reported Pediatric Quality of Life Inventory-core generic module (standardised questionnaire). Items are scored on a 0-100 scale, so that higher scores indicate better health-related quality of life

    Time frame: Post intervention (on average 8 weeks)

  8. Limited efficiency testing assessing changes in Health-related Quality of Life from pre to post intervention: proxy-reported Pediatric Quality of Life Inventory-core generic module

    Mean score recorded on the proxy-reported Pediatric Quality of Life Inventory-core generic module (standardised questionnaire). Items are scored on a 0-100 scale, so that higher scores indicate better health-related quality of life

    Time frame: Post intervention (on average 8 weeks)

  9. Feasibility: Limited efficiency testing assessing changes in Health-related Quality of Life from pre to post intervention: self-reported PedsQL-cancer module

    Mean score recorded on the self-reported Pediatric Quality of Life Inventory-cancer module (standardised questionnaire). Items are scored on a 0-100 scale, so that higher scores indicate better health-related quality of life

    Time frame: Post intervention (on average 8 weeks)

  10. Feasibility: Limited efficiency testing assessing changes in Health-related Quality of Life from pre to post intervention: proxy-reported PedsQL-cancer module

    Mean score recorded on the proxy-reported Pediatric Quality of Life Inventory-cancer module (standardised questionnaire). Items are scored on a 0-100 scale, so that higher scores indicate better health-related quality of life

    Time frame: Post intervention (on average 8 weeks)

  11. Categorisation and frequency of reported barriers to physical activity

    Categorise and collate the frequency of participant reported barriers to physical activity. Data collected during each week of the intervention period

    Time frame: Post intervention (on average 8 weeks)

  12. Categorisation and frequency of action plan strategies

    Categorise and collate the frequency of action plan items put in place to overcome barriers to physical activity. Data collected during each week of the intervention period

    Time frame: Post intervention (on average 8 weeks)

  13. Utility of physical function assessment tools, measured by completeness of assessment data for physical function

    The percentage of physical function assessments that were completed

    Time frame: Post completion of follow up assessment (on average 10 weeks)

  14. Utility of physical activity assessment tools, measured by completeness of assessment data for physical activity

    Percentage of complete Fitbit and Actigraph data days out of total assessment days

    Time frame: Post completion of follow up assessment (on average 10 weeks)

Other outcomes

  1. Construct validity of physical function measures

    Correlation between scores of all physical function measures: Timed up and Go, Movement ABC, Timed Up and Down Stairs, 6 Minute Walk Test, Time to Rise from the Floor

    Time frame: Post completion of follow up assessment (on average 10 weeks)

  2. Interpretability of physical function measures

    Interpretability assessment of all physical function measures used in the trial: Timed up and Go, Movement ABC, Timed Up and Down Stairs, 6 Minute Walk Test, Time to Rise from the Floor

    Time frame: Post completion of follow up assessment (on average 10 weeks)

  3. Responsiveness of physical function measures

    Correlation in mean change over two time points between all physical function measures used in the trial: Timed up and Go, Movement ABC, Timed Up and Down Stairs, 6 Minute Walk Test, Time to Rise from the Floor and Global Rating of Change Score

    Time frame: Post completion of follow up assessment (on average 10 weeks)

  4. Criterion validity of physical activity measured on the Fitbit and Actigraph

    Correlation of physical activity data between Fitbit and Actigraph

    Time frame: Post completion of follow up assessment (on average 10 weeks)

07

Study locations

1 site
  • Royal Children's Hospital
    Parkville, Victora 3052, Australia
08

References and documents

Publications

  • Bowen DJ, Kreuter M, Spring B, Cofta-Woerpel L, Linnan L, Weiner D, Bakken S, Kaplan CP, Squiers L, Fabrizio C, Fernandez M. How we design feasibility studies. Am J Prev Med. 2009 May;36(5):452-7. doi: 10.1016/j.amepre.2009.02.002. PubMed 19362699 ↗

Individual participant data

Plan to share: Yes — The participants will be asked to voluntarily consent to data sharing. Beginning from 3 months after article publication, the following will be made available long-term for use by future researchers from a recognised research institution whose proposed use of the data has been ethically reviewed and approved by an independent committee and who accept MCRI's conditions for access: * Individual de-identified participant data that underlie the results reported in this article (text, tables, figures and appendices) * Trial protocol, Statistical Analysis Plan, Participant Informed Consent Form

Supporting information: Study protocol, Sap, Icf

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 3, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04483362
Lead sponsor
Murdoch Childrens Research Institute
Collaborators
La Trobe University
Responsible party
Sponsor
First posted
Jul 23, 2020
Start date
Nov 9, 2020
Primary completion
Sep 3, 2021
Completion
Sep 3, 2021
Last update
Jun 3, 2022

Study contacts

Sarah L Grimshaw
principal investigator · Murdoch Children's Research Institute

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion